| Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography RJ Adams, VC McKie, L Hsu, B Files, E Vichinsky, C Pegelow, M Abboud, ... New England Journal of Medicine 339 (1), 5-11, 1998 | 2125 | 1998 |
| Iron-chelating therapy and the treatment of thalassemia NF Olivieri, GM Brittenham Blood, The Journal of the American Society of Hematology 89 (3), 739-761, 1997 | 1449 | 1997 |
| Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment MH Steinberg, F Barton, O Castro, CH Pegelow, SK Ballas, A Kutlar, ... Jama 289 (13), 1645-1651, 2003 | 1161 | 2003 |
| The β-thalassemias NF Olivieri New England journal of medicine 341 (2), 99-109, 1999 | 1157 | 1999 |
| Survival in medically treated patients with homozygous β-thalassemia NF Olivieri, DG Nathan, JH MacMillan, AS Wayne, PP Liu, A McGee, ... New England Journal of Medicine 331 (9), 574-578, 1994 | 1139 | 1994 |
| A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia MD Cappellini, A Cohen, A Piga, M Bejaoui, S Perrotta, L Agaoglu, ... Blood 107 (9), 3455-3462, 2006 | 932 | 2006 |
| A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders SP Perrine, GD Ginder, DV Faller, GH Dover, T Ikuta, HE Witkowska, ... New England Journal of Medicine 328 (2), 81-86, 1993 | 602 | 1993 |
| Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions NF Olivieri, JR Buncic, E Chew, T Gallant, RV Harrison, N Keenan, ... New England Journal of Medicine 314 (14), 869-873, 1986 | 558 | 1986 |
| Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major NF Olivieri, GM Brittenham, CE McLaren, DM Templeton, RG Cameron, ... New England Journal of Medicine 339 (7), 417-423, 1998 | 510 | 1998 |
| Iron-chelation therapy with oral deferiprone in patients with thalassemia major NF Olivieri, GM Brittenham, D Matsui, M Berkovitch, LM Blendis, ... New England Journal of Medicine 332 (14), 918-922, 1995 | 420 | 1995 |
| Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions CH Pegelow, RJ Adams, V McKie, M Abboud, B Berman, ST Miller, ... The Journal of pediatrics 126 (6), 896-899, 1995 | 418 | 1995 |
| Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial E Nisbet-Brown, NF Olivieri, PJ Giardina, RW Grady, EJ Neufeld, ... The Lancet 361 (9369), 1597-1602, 2003 | 412 | 2003 |
| Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trial EP Vichinsky, NLC Luban, E Wright, N Olivieri, C Driscoll, CH Pegelow, ... Transfusion 41 (9), 1086-1092, 2001 | 360 | 2001 |
| Secondary iron overload JP Kushner, JP Porter, NF Olivieri ASH Education Program Book 2001 (1), 47-61, 2001 | 356 | 2001 |
| Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major L Wolfe, N Olivieri, D Sallan, S Colan, V Rose, R Propper, MH Freedman, ... New England Journal of Medicine 312 (25), 1600-1603, 1985 | 335 | 1985 |
| Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study J Porter, R Galanello, G Saglio, EJ Neufeld, E Vichinsky, MD Cappellini, ... European journal of haematology 80 (2), 168-176, 2008 | 311 | 2008 |
| Stroke prevention trial in sickle cell anemia RJ Adams, VC McKie, D Brambilla, E Carl, D Gallagher, FT Nichols, ... Controlled clinical trials 19 (1), 110-129, 1998 | 301 | 1998 |
| Bone disease in thalassemia: a frequent and still unresolved problem MG Vogiatzi, EA Macklin, EB Fung, AM Cheung, E Vichinsky, N Olivieri, ... Journal of Bone and Mineral Research 24 (3), 543-557, 2009 | 281 | 2009 |
| Inherited disorders of hemoglobin D Weatherall, O Akinyanju, S Fucharoen, N Olivieri, P Musgrove Disease Control Priorities in Developing Countries. 2nd edition, 2006 | 246 | 2006 |
| Experimental verocytotoxemia in rabbits SE Richardson, TA Rotman, V Jay, CR Smith, LE Becker, M Petric, ... Infection and immunity 60 (10), 4154-4167, 1992 | 239 | 1992 |
